`
`A0120 (Rev. OSIUJ‘
`
`TO:
`
`Mail Stop 8
`Directer efthe US. Patent and "Trademark Office
`?.O. Box 1450
`Alexandria, VA 22313-1450
`
`TRADEMARK
`
`REPORT ON THE
`I"! LING 0R DETERMINATION OF AN
`ACTION REGARDENG A PATENT OR
`
`[11 Compliance with 35 1.38.6. § 29!) and/or 15 U.S.C. § ll 16 you are hereby advised that a court action has been
`
` filed in the US. District Court for the District of Delaware
`on the following,
`E] 'i‘i'atleiiiatks or
`Ml’ziieuis.
`( 1':-
`ttie patent action involves 35 USE. § 292.):
`
`1?.S.DESTRECT COURT
`DATE FlLED
`
`
`
`for the District of Delaware
`8.’24!201 7
`
`DEFENDANT
` PLAlN'l‘ 5 Fl"
`
`
`
`
`FRESENIUS KABI USA, LLC
`
`TEVA PHARMACEUTECALS ENTERNATIONAL GMBH,
`
`el al.
`
`
`
`PATENT OR
`DATE OF PATENT
`w
`R l"
`
`
`TRADEMARK NO
`OR. TRADEMARK
`HOLDER 0F PATENT OR TRAUEM'
`
`
`
`
`
`
`
`
`
`
`
`7. US 8191270 82 — Cephaion, inc.
`
`
`
`
`
`5 US 9,144,568 81
`
`
`
`9i29l2015
`
`Eagle Pharmaceuticals, inc.
`
`Eagle Pharmaceuticals, inc.
`
`In the above—entitled case, the following patenttsli' trademarkts) have been included:
`
`
`' iNCLL‘ DED BY
`'
`DATE {NLLUDDD
`
`
`
`
`fl Amendment
`[3 Answer
`[3 Other Pleading
`D Cress Bill
`
`
`
`
`
`HOLDER OF PATENT OR TRADEMARK
`PATENT OR
`DATE OF PATENT
`
`
`TRADEMARK Ni),
`OR "m AI)EM,RK
`
`
`——
`
`
`
`
`
`in tile above-u-emilled case. the following decision. has been rendered orjudgemem issued:
`
`DEClSlONEJUDGl-EMENT
`
`
`
`
`{BY} DEPUTY CLERK
`
`Copy inn-linen initiation of action, mail this eepy tn Director Copy Zip—U Don termination of anion, mail this cum to Direetnr
`(Tepy 2—w-Upon filing dticument adding pzitentfi), mail this copy t0 Directer Copy 4—4321“: file copy
`
`